EUVIMEDEUVIMED entdecken
Fallbericht

Sarcomatous Transformation of an IDH ‐Mutant Astrocytoma With an Oligosarcoma‐Like Methylation Profile

Jing Liu, Caiyan Wen, Fan Lin, Xia Liu

Neuropathology · 2026-08 · 46 (4)

DOI: 10.1111/neup.70069 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology, online erschienen am 07.07.2026. Verfasst von Jing Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Astrocytoma, Isocitrate Dehydrogenase, Brain Neoplasms, Sarcoma. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Sanming Project of Medicine in Shenzen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a rare case of oligosarcoma, IDH‐mutant, arising from a recurrent astrocytoma in a male in his 50s. The patient was originally diagnosed with IDH‐mutant astrocytoma, CNS WHO grade 2, lacking 1p/19q co‐deletion. At recurrence, the tumor exhibited a pure spindle cell sarcoma morphology, with retained IDH1 R132H, ATRX, and TP53 mutations, homozygous CDKN2A/B deletion, and a methylation profile classifying it as oligosarcoma, IDH‐mutant. Although next‐generation sequencing (NGS) suggested non‐specific partial 1p/19q deletion signals, a true whole‐arm 1p/19q co‐deletion was not confirmed by fluorescence in situ hybridization (FISH) or methylation‐based copy‐number analysis, as shown in Figure 4E. Only two prior reports describe oligosarcoma arising from astrocytoma. Based on the sarcomatous morphology, astrocytic molecular background, and methylation clustering, we interpret this case as post‐treatment sarcomatous transformation of an IDH‐mutant astrocytoma, CNS WHO grade 2, rather than a canonical oligosarcoma. This case highlights the limitations of methylation profiling in heavily treated gliomas and underscores the importance of multimodal molecular confirmation in diagnostically challenging tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaIsocitrate DehydrogenaseBrain NeoplasmsSarcomaCell Transformation, NeoplasticHumansMaleDNA MethylationMiddle AgedMutationNeoplasm Recurrence, Local

Stichwörter der Autor:innen

1p/19qDNA methylationIDH mutationastrocytomagliosarcomaoligosarcoma

Substanzen

Isocitrate DehydrogenaseIDH1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen, China.
  • Department of Radiology, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen, China.

Förderung

  • Sanming Project of Medicine in Shenzen Municipality

Zitieren

APA

Liu, J., Wen, C., Lin, F., & Liu, X. (2026). Sarcomatous Transformation of an IDH ‐Mutant Astrocytoma With an Oligosarcoma‐Like Methylation Profile. Neuropathology, 46(4). https://doi.org/10.1111/neup.70069

Vancouver

Liu J, Wen C, Lin F, Liu X. Sarcomatous Transformation of an IDH ‐Mutant Astrocytoma With an Oligosarcoma‐Like Methylation Profile. Neuropathology. 2026;46(4). doi:10.1111/neup.70069

BibTeX
@article{Liu2026,
  author = {Liu, Jing and Wen, Caiyan and Lin, Fan and Liu, Xia},
  title = {Sarcomatous Transformation of an IDH ‐Mutant Astrocytoma With an Oligosarcoma‐Like Methylation Profile},
  journal = {Neuropathology},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1111/neup.70069}
}
Kostenlos starten →